within Pharmacolibrary.Drugs.ATC.C;

model C05AA12
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 2.8333333333333332e-05,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.086,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C05AA12</td></tr><td>route:</td><td>intramuscular</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Triamcinolone is a synthetic corticosteroid with glucocorticoid activity, used for its anti-inflammatory and immunosuppressive effects. It is indicated for various conditions including allergic reactions, dermatological diseases, and as a local treatment for joint inflammation. It is approved and widely used clinically in multiple formulations.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects after intramuscular administration of triamcinolone acetonide.</p><h4>References</h4><ol><li><p>Shahinfar, S, &amp; Maibach, H (2023). Enigma of Intramuscular Triamcinolone Acetonide (Kenalog. <i>Clinical pharmacokinetics</i> 62(9) 1189–1199. DOI:<a href=&quot;https://doi.org/10.1007/s40262-023-01297-5&quot;>10.1007/s40262-023-01297-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37598107/&quot;>https://pubmed.ncbi.nlm.nih.gov/37598107</a></p></li><li><p>Knych, HK, et al., &amp; McKemie, DS (2013). Pharmacokinetics of triamcinolone acetonide following intramuscular and intra-articular administration to exercised Thoroughbred horses. <i>Equine veterinary journal</i> 45(6) 715–720. DOI:<a href=&quot;https://doi.org/10.1111/evj.12059&quot;>10.1111/evj.12059</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23574452/&quot;>https://pubmed.ncbi.nlm.nih.gov/23574452</a></p></li><li><p>Soma, LR, et al., &amp; Boston, RC (2011). Pharmacokinetics of intra-articular, intravenous, and intramuscular administration of triamcinolone acetonide and its effect on endogenous plasma hydrocortisone and cortisone concentrations in horses. <i>American journal of veterinary research</i> 72(9) 1234–1242. DOI:<a href=&quot;https://doi.org/10.2460/ajvr.72.9.1234&quot;>10.2460/ajvr.72.9.1234</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21879982/&quot;>https://pubmed.ncbi.nlm.nih.gov/21879982</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C05AA12;
